APA (7th ed.) Citation

McKeown, S., Cunningham, F., Harkin, L., Lunn, K., Fraser, A., Imlach, S., . . . O'Neill, C. (2026). ANGICYTE - ADVANCING ECFC MANUFACTURING FOR REGENERATIVE TREATMENT OF ISCHAEMIC EYE DISEASE. Cytotherapy (Elsevier Inc.), 28(5), N.PAG. https://doi.org/10.1016/j.jcyt.2026.102388

Chicago Style (17th ed.) Citation

McKeown, S.D, F. Cunningham, L. Harkin, K. Lunn, A.R Fraser, S. Imlach, K. Samuel, and C. O'Neill. "ANGICYTE - ADVANCING ECFC MANUFACTURING FOR REGENERATIVE TREATMENT OF ISCHAEMIC EYE DISEASE." Cytotherapy (Elsevier Inc.) 28, no. 5 (2026): N.PAG. https://doi.org/10.1016/j.jcyt.2026.102388.

MLA (9th ed.) Citation

McKeown, S.D, et al. "ANGICYTE - ADVANCING ECFC MANUFACTURING FOR REGENERATIVE TREATMENT OF ISCHAEMIC EYE DISEASE." Cytotherapy (Elsevier Inc.), vol. 28, no. 5, 2026, p. N.PAG, https://doi.org/10.1016/j.jcyt.2026.102388.